Expression and coreceptor activity of STRL33/Bonzo on primary peripheral blood lymphocytes

Blood

Volumn 96, Issue 1, 2000, Pages 41-49

  Sharron, Matthew ^a   Pöhlmann, Stefan ^a   Price, Ken ^a   Lolis, Elias ^a   Tsang, Monica ^a   Kirchhoff, Frank ^a   Doms, Robert W ^a   Lee, Benhur ^a  

^a Abramson Bldg ^*

Author keywords

[No Author keywords available]

Indexed keywords

1,1' [1,4 PHENYLENEBIS(METHYLENE)]BIS(1,4,8,11 TETRAAZACYCLOTETRADECANE); CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR4 ANTAGONIST; UNCLASSIFIED DRUG; VIRUS RECEPTOR; VIRUS RECEPTOR STRL 33;

ANTIBODY PRODUCTION; ARTICLE; BINDING SITE; CYTOKINE RELEASE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; TUMOR ASSOCIATED LEUKOCYTE;

EID: 0342995872     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.1.41     Document Type: Article

References (54)

1. Moore JP, Trkola A, Dragic T. Co-receptors for HIV-1 entry. Curr Opinion Immunol. 1997;9:551-562.
2. Doms RW, Peiper SC. Unwelcome guests with master keys: how HIV uses chemokine receptors for cellular entry. Virology. 1997;235:179-190.
3. Bieniasz PD, Cullen BR. Chemokine receptors and human immunodeficiency virus infection. Frontiers Biosci. 1998;3:44-58.
4. Berger EA, Murphy PM, Farber JM. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu Rev Immunol. 1999;17:657-700.
5. Doms RW, Edinger AL, Moore JP. Coreceptor use by primate lentiviruses: human retroviruses and AIDS 1998. Los Alamos, NM, Los Alamos National Laboratory: Theoretical Biology and Biophysics, 1998.
6. Chen Z, Zhou P, Ho DD, Landau NR, Marx PA. Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry. J Virol. 1997;71:2705-2714.
7. Hill CM, Deng H, Unutmaz D, et al. Envelope glycoproteins from human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus can use human CCR5 as a coreceptor for viral entry and make direct CD4-dependent interactions with this chemokine receptor. J Virol. 1997; 71:6296-6304.
8. Kirchhoff F, Pohlmann S, Hamacher M, et al. Simian immunodeficiency virus variants with differential T-cell and macrophage tropism use CCR5 and an unidentified cofactor expressed in CEMX174 cells for efficient entry. J Virol. 1997; 71:6509-6516.
9. Deng H, Unutmaz D, Kewalramani VN, Littman DR. Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature. 1997;388:296-300.
10. Edinger AL, Hoffman TL, Yi Y, et al. An orphan seven transmembrane domain receptor expressed widely in brain functions as a coreceptor for HIV-1 and SIV. J Virol. 1998;72:7934-7940.
11. Edinger AL, Hoffman TL, Sharron M, et al. Use of GPR1, GPR15, and STRL33 as coreceptors by diverse HIV-1 and SIV envelope proteins. Virology. 1998;249:367-378.
12. Farzan M, Choe H, Martin K, et al. Two orphan seven-transmembrane segment receptors which are expressed in CD4-positive cells support simian immunodeficiency virus infection. J Exp Med. 1997;186:405-411.
13. Samson M, Edinger AL, Stordeur P, et al. ChemR23, a putative chemoattractant receptor, is expressed in dendritic cells and is a coreceptor for SIV and some primary HIV-1 strains. Eur J Immunol. 1998;28:1688-1700.
14. Choe H, Farzan M, Konkel M, et al. The orphan seven-transmembrane receptor apj supports the entry of primary T-cell-line-tropic and dualtropic human immunodeficiency virus type 1. J Virol. 1998;72:6113-6118.
15. Liao F, Alkhatib G, Peden KWC, et al. STRL33, a novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophage-tropic and T cell line-tropic HIV-1. J Exp Med. 1997;185: 2015-2023.
16. Pohlmann S, Krumbiegel M, Kirchhoff F. Coreceptor usage of BOB/GPR15 and Bonzo/ STRL33 by primary isolates of human immunodeficiency virus type 1. J Gen Virol. 1999;80:1241-1251.
17. Zhang YJ, Dragic T, Cao Y et al. Use of coreceptors other than CCR5 by non-syncytium-inducing adult and pediatric isolates of human immunodeficiency virus type 1 is rare in vitro. J Virol. 1998; 72:9337-9344.
18. Zhang YJ, Moore JP. Will multiple coreceptors need to be targeted by inhibitors of human immunodeficiency virus type 1 entry? J Virol. 1999;73: 3443-3448.
19. King A, Jokhi PP, Burrows TD, et al. Functions of human decidual NK cells. Am J Reprod Immunol. 1996;35:258-260.
20. Moller MJ, Krammerer R, von Kliest S. Adistinct distribution of natural killer cell subgroups in human tissue and blood. Int J Cancer. 1998;78:533-538.
21. Chen BK, Saksela K, Andino R, Baltimore D. Distinct modes of human immunodeficiency virus type 1 proviral latency revealed by superinfection of nonproductively infected cell lines with recombinant luciferase-encoding viruses. J Virol. 1994; 68:654-660.
22. Connor RI, Chen BK, Choe S, Landau NR. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology. 1995;206:935-944.
23. Lee B, Sharron M, Blanpain C, et al. Epitope mapping of CCR5 reveals multiple conformational states and distinct but overlapping structures involved in chemokine and coreceptor function. J Biol Chem. 1999;274:9617-9626.
24. Lee B, Sharron M, Montaner LJ. Weissman D, Doms RW. Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages. Proc Natl Acad Sci U S A. 1999;96:5215-5220.
25. Whiteside TL, Herberman RB. Role of human natural killer cells in health and disease. Clin Diag Lab Immunol. 1994;1:125-133.
26. Robertson MJ. Natural killer cell clinical studies: surface antigens of human natural killer cells in health and disease. In: Kishimoto T, Kikutani H, Borner A, et al, eds. Leukocyte Typing VI: White Cell Differentiation Antigens. New York, NY: Garland Publishing Inc; 1998:327-330.
27. Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol. 1999;17:189-220.
28. Platt EJ, Wehrly K, Kuhnman SE, Chesbro B, Kabat D. Effects of CCR5 and CD4 cell surface concentrations on infections by macrophage-tropic isolates of human immunodeficiency virus type 1. J Virol. 1998;72:2855-2864.
29. Kozak SL, Platt EJ, Madani N, et al. CD4, CXCR-4, and CCR5 dependencies for infections by primary patient and laboratory-adapted isolates of human immunodeficiency virus type 1. J Virol. 1997;71:873-882.
30. Rucker J, Edinger AL, Sharron M, et al. Utilization of chemokine receptors, orphan receptors, and herpesvirus encoded receptors by diverse human and simian immunodeficiency viruses. J Virol. 1997;71:8999-9007.
31. Edinger AL, Blanpain C, Kunstman KJ, et al. Functional dissection of CCR5 coreceptor function through the use of CD4-independent simian immunodeficiency virus strains. J Virol. 1999;73: 4062-4073.
32. Lee B, Doranz BJ, Rana S, et al. Influence of the CCR2-V641 polymorphism on HIV-1 coreceptor activity and chemokine receptor function of CCR2b, CCR3, CCR5, and CXCR4. J Virol. 1998;72:7450-7458.
33. Edinger AL, Mankowski JL, Doranz BJ, et al. CD4-independent, CCR5-dependent infection of brain capillary endothelial cells by a neurovirulent simian immunodeficiency virus strain. Proc Natl Acad Sci U S A. 1997;94:14742-14747.
34. Olson WC, Rabut GE, Nagashima KA, et al. Differential inhibition of human immunodeficiency virus type 1 fusion, gp120 binding, and CC-chemokine activity by monoclonal antibodies to CCR5. J Virol. 1999;73:4145-4155.
35. Wu L, LaRosa G, Kassam N, et al. Interaction of chemokine receptor CCR5 with its ligands: multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding. J Exp Med. 1997;186:1373-1381.
36. Schols D, Struyf S, Van Damme J, et al. Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4. J Exp Med. 1997;186:1383-1368.
37. Donzella GA, Schols D, Lin SW, et al. AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor. Nat Med. 1998;4:72-77.
38. Piguet V, Schwartz O, Le Gall S, Trono D. The downregulation of CD4 and MHC-I by primate lentiviruses: a paradigm for the modulation of cell surface receptors. Immunol Rev. 1999;168:51-63.
39. Horuk R, Hesselgesser J, Zhou Y, et al. The CC chemokine 1309 is a functional ligand for ChemR1/CCR8 and inhibits ChemR1/CCR8 dependent infection by diverse HIV-1 strains. J Biol Chem. 1998;273:386-391.
40. Reeves JD, McKnight A, Potempa S, et al. CD4-independent infection by HIV-2 (ROD/B): use of the 7-transmembrane receptors CXCR-4, CCR-3, and V28 tor entry. Virology. 1997;231:130-134.
41. Singh A, Besson G, Mobasher A, Collman RG. Patterns of chemokine receptor fusion cofactor utilization by human immunodeficiency virus type 1 variants from the lungs and blood. J Virol. 1999; 73:6680-6690.
42. Schols D, Struyf S, Van Damme J, et al. Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4. J Exp Med. 1997;186:1383-1388.
43. D'Arena G, Musto P, Cascavilla N, et al. Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features. Haematologica. 1998;83:197-203.
44. Papadogiannakis N. Traffic of leukocytes through the maternofetal interface and its possible consequences. Curr Top Microbiol Immunol. 1997;222: 141-157.
45. King A, Burrows T, Loke YW. Human uterine natural killer cells. Nat Immun. 1996;15:41-52.
46. Schenten D, Marcon L, Karlsson GB, et al. Effects of soluble CD4 on simian immunodeficiency virus infection of CD4-positive and CD4-negative cells. J Virol. 1999;73:5373-5380.
47. Speck RF, Esser U, Penn ML, et al. A trans-receptor mechanism for infection of CD4-negative cells by human immunodeficiency virus type 1. Curr Biol. 1999;9:547-550.
48. Kurosawa S, Matsuzaki G, Harada M, Ando T, Nomoto K. Early appearance and activation of natural killer cells in tumor-infiltrating lymphoid cells during tumor development. Eur J Immunol. 1993;23:1029-1033.
49. Kurosawa S, Harada M, Matsuzaki G, et al. Early-appearing tumour-infiltrating natural killer cells play a crucial role in the generation of anti-tumour T lymphocytes. Immunology. 1995;85:338-346.
50. LeFever AV, Funahashi A. Phenotype and function of natural killer cells in patients with bronchogenic carcinoma. Cancer Res. 1991;51:5596-5601.
51. Yi Y, Isaacs SN, Williams DA, et al. Role of CXCR4 in cell-cell fusion and infection of monocyte-derived macrophages by primary human immunodeficiency virus type 1 (HIV-1) strains: two distinct mechanisms of HIV-1 dual tropism. J Virol. 1999;73:7117-7125.
52. Yi Y, Rana S, Turner JD, Gaddis N, Collman RG. CXCR4 is expressed by primary macrophages and supports CCR5-independent infection by dual-tropic but not T-tropic isolates of HIV-1. J Virol. 1998;72:772-777.
53. Chen Z, Kwon D, Jin Z, et al. Natural infection of a homozygous delta24 CCR5 red-capped mangabey with an R2b-tropic simian immunodeficiency virus. J Exp Med. 1998;188:2057-2065.
54. Pohlmann S, Lee B, Meister S, et al. SIVmac utilizes human and sooty mangabey but not rhesus macaque STRL33 for efficient entry. J Virol. 2000;74:5075-5082.